Emcure Pharmaceuticals Limited (NSE:EMCURE)
India flag India · Delayed Price · Currency is INR
1,361.40
-14.50 (-1.05%)
At close: Jun 13, 2025, 3:30 PM IST

Emcure Pharmaceuticals Statistics

Total Valuation

NSE:EMCURE has a market cap or net worth of INR 258.00 billion. The enterprise value is 267.76 billion.

Market Cap 258.00B
Enterprise Value 267.76B

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date n/a

Share Statistics

NSE:EMCURE has 189.51 million shares outstanding. The number of shares has increased by 3.40% in one year.

Current Share Class 189.51M
Shares Outstanding 189.51M
Shares Change (YoY) +3.40%
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 72.90%
Owned by Institutions (%) 2.84%
Float 20.38M

Valuation Ratios

The trailing PE ratio is 37.37 and the forward PE ratio is 27.59. NSE:EMCURE's PEG ratio is 1.06.

PE Ratio 37.37
Forward PE 27.59
PS Ratio 3.27
PB Ratio 5.56
P/TBV Ratio 7.37
P/FCF Ratio 40.96
P/OCF Ratio 30.29
PEG Ratio 1.06
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.23, with an EV/FCF ratio of 42.51.

EV / Earnings 39.30
EV / Sales 3.39
EV / EBITDA 18.23
EV / EBIT 24.68
EV / FCF 42.51

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.22.

Current Ratio 1.71
Quick Ratio 0.86
Debt / Equity 0.22
Debt / EBITDA 0.70
Debt / FCF 1.62
Interest Coverage 6.17

Financial Efficiency

Return on equity (ROE) is 18.23% and return on invested capital (ROIC) is 12.19%.

Return on Equity (ROE) 18.23%
Return on Assets (ROA) 8.45%
Return on Invested Capital (ROIC) 12.19%
Return on Capital Employed (ROCE) 19.49%
Revenue Per Employee 7.28M
Profits Per Employee 627,840
Employee Count 10,852
Asset Turnover 0.98
Inventory Turnover 1.79

Taxes

In the past 12 months, NSE:EMCURE has paid 2.64 billion in taxes.

Income Tax 2.64B
Effective Tax Rate 27.17%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1,132.02
200-Day Moving Average 1,261.00
Relative Strength Index (RSI) 68.58
Average Volume (20 Days) 263,930

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:EMCURE had revenue of INR 78.96 billion and earned 6.81 billion in profits. Earnings per share was 36.43.

Revenue 78.96B
Gross Profit 47.49B
Operating Income 10.85B
Pretax Income 9.71B
Net Income 6.81B
EBITDA 14.69B
EBIT 10.85B
Earnings Per Share (EPS) 36.43
Full Income Statement

Balance Sheet

The company has 2.41 billion in cash and 10.23 billion in debt, giving a net cash position of -7.81 billion or -41.23 per share.

Cash & Cash Equivalents 2.41B
Total Debt 10.23B
Net Cash -7.81B
Net Cash Per Share -41.23
Equity (Book Value) 46.42B
Book Value Per Share 234.60
Working Capital 18.88B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.52 billion and capital expenditures -2.22 billion, giving a free cash flow of 6.30 billion.

Operating Cash Flow 8.52B
Capital Expenditures -2.22B
Free Cash Flow 6.30B
FCF Per Share 33.24
Full Cash Flow Statement

Margins

Gross margin is 60.15%, with operating and profit margins of 13.74% and 8.63%.

Gross Margin 60.15%
Operating Margin 13.74%
Pretax Margin 12.30%
Profit Margin 8.63%
EBITDA Margin 18.60%
EBIT Margin 13.74%
FCF Margin 7.98%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.22%.

Dividend Per Share 3.00
Dividend Yield 0.22%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.40%
Shareholder Yield -3.18%
Earnings Yield 2.64%
FCF Yield 2.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7